In summary, our study identified six central genes (G6PD, PKM, ENO3, PFKL, PGD, and TALDO1) differentially expressed in AD and T2DM patients, which are involved in key glucose metabolism pathways. This evidence concerns the gene PFKL and Alzheimer disease.